Douglas Joseph Hirsch - 16 Jun 2026 Form 4 Insider Report for GoodRx Holdings, Inc. (GDRX)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
17 Jun 2026, 20:31:16 UTC
Prior SEC filing
29 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Gracye Cheng, Attorney-in-Fact for Douglas Joseph Hirsch

Key filing fact

Douglas Joseph Hirsch filed Form 4 for GoodRx Holdings, Inc. (GDRX) on 17 Jun 2026.

Key facts

  • This page summarizes Douglas Joseph Hirsch's Form 4 filing for GoodRx Holdings, Inc. (GDRX).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 17 Jun 2026, 20:31.

Change

  • Previous filing in this sequence was filed on 29 May 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001822522 Primary reporting owner

Hirsch Douglas Joseph

Relationship
Director
Address
C/O GOODRX HOLDINGS, INC., 2701 OLYMPIC BOULEVARD, SANTA MONICA
Signature
/s/ Gracye Cheng, Attorney-in-Fact for Douglas Joseph Hirsch
Signature date
17 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GDRX transaction

Class A Common Stock

Award

Transaction value
Shares
+73,434
Change %
+30%
Price
$0.000000*
Shares after
320,936
Date
16 Jun 2026
Ownership
Direct
Footnotes
F1
GDRX holding

Class A Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
543,377
Date
16 Jun 2026
Ownership
By DH 2024-2 GRAT
Footnotes
F2
GDRX holding

Class A Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
2,089,343
Date
16 Jun 2026
Ownership
By DH 2025 GRAT
Footnotes
F3
GDRX holding

Class A Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1
Date
16 Jun 2026
Ownership
By Spouse
GDRX holding

Class A Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
2,089,343
Date
16 Jun 2026
Ownership
By CH 2025 GRAT
Footnotes
F4
GDRX holding

Class A Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
543,377
Date
16 Jun 2026
Ownership
By CH 2024-2 GRAT
Footnotes
F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Reflects deferred stock units. Each deferred stock unit represents a contingent right to receive one share of Class A common stock. The deferred stock units vest in full on the earlier of (i) the one-year anniversary of June 16, 2026 and (ii) the date of the 2027 Annual Meeting of Stockholders, subject to Reporting Person's continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2029; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors).

Footnote F2

Share held directly by DH 2024 -2 GRAT, a grantor retained annuity trust (the "DH 2024-2 GRAT"). The Reporting Person serves as the sole trustee and sole annuitant of the DH 2024-2 GRAT.

Footnote F3

Share held directly by DH 2025 GRAT, a grantor retained annuity trust (the "DH 2025 GRAT"). The Reporting Person serves as the sole trustee and sole annuitant of the DH 2025 GRAT.

Footnote F4

Share held directly by CH 2025 GRAT, a grantor retained annuity trust (the "CH 2025 GRAT"). Chona Hirsch, the Reporting Person's spouse, serves as the sole trustee and sole annuitant of the CH 2025GRAT. The Reporting Person has no pecuniary interest in or voting or investment control over the shares of Class A Common Stock held by the CH 2025 GRAT and disclaims beneficial ownership of such shares. This filing is not an admission or acknowledgment that the Reporting Person is the beneficial owner of such shares.

Footnote F5

Share held directly by CH 2024-2 GRAT, a grantor retained annuity trust (the "CH 2024-2 GRAT"). Chona Hirsch, the Reporting Person's spouse, serves as the sole trustee and sole annuitant of the CH 2024-2 GRAT. The Reporting Person has no pecuniary interest in or voting or investment control over the shares of Class A Common Stock held by the CH 2024-2 GRAT and disclaims beneficial ownership of such shares. This filing is not an admission or acknowledgment that the Reporting Person is the beneficial owner of such shares.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .